BAY 94-9343 Uses, Dosage, Side Effects and more
BAY 94-9343 is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).
| Attribute | Details |
|---|---|
| Trade Name | BAY 94-9343 |
| Generic | Anetumab ravtansine |
| Anetumab ravtansine Other Names | Anetumab ravtansine, BAY 94-9343 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
